Skip to main content
IRIDEX CORP logo

IRIDEX CORP — Investor Relations & Filings

Ticker · IRIX ISIN · US4626841013 US Manufacturing
Filings indexed 1,017 across all filing types
Latest filing 2025-11-17 Director's Dealing
Country US United States of America
Listing US IRIX

About IRIDEX CORP

https://www.iridex.com/

IRIDEX Corporation is an ophthalmic medical technology company that develops, manufactures, and markets laser-based medical systems, delivery devices, and consumable instrumentation. The company's products are used to treat a range of serious eye diseases, with a primary focus on glaucoma, diabetic macular edema (DME), and other retinal conditions. Its portfolio features proprietary MicroPulse® laser technology, a tissue-sparing treatment modality integrated into systems like the Cyclo G6® for glaucoma and the PASCAL® platform for retinal photocoagulation. IRIDEX provides comprehensive solutions for ophthalmologists in office-based practices, hospitals, and ambulatory surgical centers.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2025-11-17 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-12 English
8-K
Regulatory Filings
2025-11-12 English
4
Director's Dealing
2025-10-02 English
4
Director's Dealing
2025-09-15 English
4
Director's Dealing
2025-09-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.